Biocide use and antibiotic resistance: The relevance of laboratory findings to clinical and environmental situations

Lancet Infectious Diseases

Volumn 3, Issue 12, 2003, Pages 794-803

  Russell, A D ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL DERIVATIVE; AMINOCYCLITOL; AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; BENZALKONIUM CHLORIDE; BETA LACTAM ANTIBIOTIC; BIGUANIDE DERIVATIVE; BIOCIDE; CETRIMIDE; CHLORAMPHENICOL; CHLORHEXIDINE; CYANURIC ACID; ERYTHROMYCIN; ETHYLENE OXIDE DERIVATIVE; FORMALDEHYDE; GLUTARALDEHYDE; HYPOCHLORITE SODIUM; ISONIAZID; ISOTHIAZOLE DERIVATIVE; PENTAMIDINE; PHENOL DERIVATIVE; PHTHALALDEHYDE; POLY(HEXAMETHYLENEBIGUANIDE); RIFAMPICIN; SULFONAMIDE; TETRACYCLINE DERIVATIVE; TRICLOSAN; TRIMETHOPRIM; UNINDEXED DRUG;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTISEPSIS; BACTERICIDAL ACTIVITY; BIOFILM; CONCENTRATION RESPONSE; CONTACT SENSITIVITY; DISINFECTION; HUMAN; LABORATORY DIAGNOSIS; LABORATORY TEST; MATERIALS TESTING; MICROORGANISM DETECTION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PH MEASUREMENT; PRIORITY JOURNAL; REVIEW; SANITATION; STRESS; TEMPERATURE MEASUREMENT;

EID: 0344552435     PISSN: 14733099     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1473-3099(03)00833-8     Document Type: Review

References (130)

1. McDonnell G, Russell AD. Antiseptics and disinfectants: activity, action and resistance. Clin Microbiol Rev 1999; 12: 147-79.
2. Pittet D, Boyce JM. Hand hygiene and patient care: pursuing the Semmelweis legacy. Lancet Infect Dis 2001; April: 9-20.
3. Health Council of the Netherlands. Disinfectants in consumer products. The Hague: Health Council of the Netherlands, 2001: Publication no. 2001/05E.
4. Levy SB. Factors impacting on the problems of antibiotic resistance. J Antimicrob Chemother 2002; 49: 25-30.
5. Russell AD. Do biocides select for antibiotic resistance? J Pharm Pharmacol 2000; 52: 227-33.
6. Russell AD. Bacterial resistance to disinfectants: present knowledge and future problems. J Hosp Infect 1999; 43: S57-68.
7. Russell AD, McDonnell G. Concentration: a major factor in studying biocidal action. J Hosp Infect 2000; 44: 1-3.
8. Thomas L, Lambert RJW, Maillard J.Y, Russell AD. Development of resistance to chlorhexidine diacetate in Pseudomonas aeruginosa and the effect of a residual concentration. J Hosp Infect 2000; 46: 297-303.
9. Russell AD, Chopra I. Understanding antibacterial action and resistance, 2nd edn. Chichester, UK: Ellis Horwood, 1996.
10. Cremieux A, Freney J, Davin-Regli A. Methods of testing disinfectants. In: Block SS, ed. Disinfection, sterilization and presentation, 5th edn. Philadelphia, USA: Lippincott Williams & Wilkins, 2001. 1305-27.
11. Andrews JM. The development of the BSAC standardization method of disc diffusion testing. J Antimicrob Chemother 2001; 48 (suppl S1): 29-42.
12. Jones RD. Bacterial resistance and topical antimicrobial wash products. Am J Infect Control 1999; 27: 351-63.
13. Russell AD. Introduction of biocides into clinical practice and the impact on antibiotic resistance. J Appl Microbiol 2002; 92: 121S-35S.
14. Vischer WA, Regos J. Antimicrobial spectrum of triclosan, a broad-spectrum antimicrobial agent for topical application. Zentralbl Bakteriol [A] 1974; 226: 376-89.
15. Chuanchen R, Kirkhoff-Schweizer RR, Schweizer HP. High-level triclosan resistance in Pseudomonas aeruginosa is solely a result of efflux. Am J Infect Control 2003; 31: 124-27.
16. Favero MS. Products containing biocides: perceptions and realities. J Appl Microbiol 2002; 92: 72S-77S.
17. Suller MTE, Russell AD. Antibiotic and biocide resistance in methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococcus. J Hosp Infect 1999; 43: 281-91.
18. Suller MTE, Russell AD. Triclosan and antibiotic resistance in Staphylococcus aureus. J Antimicrob Chemother 2000; 46: 11-18.
19. Bamber Al, Neal TJ. AN assessment of triclosan susceptibility in methicillin-resistant and methicillin-sensitive Staphylococcus aureus. J Hosp Infect 1999; 41: 107-09.
20. Cookson BD, Farrelly H, Stapleton P, Garvey RP, Price MR Transferable resistance to triclosan in MRSA. Lancet 1991; 337:1548-49.
21. Al-Doori Z, Morrison D, Edwards G, Gemmell C. Susceptibility of MRSA to triclosan. J Antimicrob Chemother 2003; 51: 185-86.
22. Storz G, Hengge-Aronis R. Preface. In: Storz G, Hengge-Aronis R, eds. Bacterial stress responses. Washington DC: ASM Press, 2000: xiii-xiv.
23. Storz G, Zheng M. Oxidative stress. In: Storz G, Hengge-Aronis R, eds. Bacterial stress responses. Washington DC: ASM Press, 2000:47-59.
24. Gilbert P, Allison DG, McBain AJ. Biofilms in vitro and in vivo: do singular mechanisms imply cross-resistance? J Appl Microbiol 2002; 92: 98S-110S.
25. Denyer SP, Stewart GSAB. Mechanism of action of disinfectants. Int Biodet Biodeg 1998; 41: 261-68.
26. McMurry LM, McDermott PF, Levy SB. Genetic evidence that InhA of Mycobacterium smegmatis is a target for triclosan. Antimicrob Agents Chemother 1999; 43: 711-13.
27. Russell AD. Mechanisms of action of antiseptics and disinfectants: an increasingly important area of investigation. J Antimicrob Chdemother 2002; 49: 597-99.
28. Russell AD. Biocides and pharmacologically active drugs as residues in the environment: is there a correlation with antibiotic resistance? Am J Infect Control 2002; 30: 495-98.
29. Hiramatsu K. Vancomycin-resistant Staphylococcus aureus: a new model of antibiotic resistance. Lancet Infect Dis 2001; 1: 147-55.
30. Fraise AP.Susceptibility of antibiotic-resistant cocci to biocides. J Appl Microbiol 2002; 92:158S-62S.
31. Sulavik MC, Houseweart C, Cramer C, et al. Antibiotic susceptibility profiles of Escherichia coli lacking multidrug efflux pumps. Antimicrob Agents Chemother 2001; 45: 1126-36.
32. Chung YJ, Saier Jr, MH. SMR-type multidrug resistance pumps. Curr Opin Drug Disc Devel 2001; 4: 237-45.
33. Poole K. Mechanisms of bacterial biocide and antibiotic resistance. J Appl Microbiol 2002; 92: 55S-64S.
34. Levy SB. Active efflux: a common mechanism for biocide and antibiotic resistance. J Appl Microbiol 2002; 92: 65S-71S.
35. McMurry LM, Oethinger M, Levy SB. Triclosan targets lipid synthesis. Nature 1998; 394: 531-32.
36. Fan F, Yan K, Wallis GS, et al. Defining and combating the mechanisms of triclosan resistance in clinical isolates of Staphylococcus aureus. Antimicrob Agents Chemother 2002; 46: 3343-47.
37. Russell AD, Tattawasart U, Maillard J-Y, Furr JR. Possible link between bacterial resistance and and use of antibiotics and biocides. Antimicrob Agents Chemother 1998; 42: 2151.
38. Tattawasart U, Maitlard J-Y, Furr JR, Russell AD. Development of resistance to chlorhexidine diacetate and cetylpyridinium chloride in Pseudomonas stutzeri and changes in antibiotic susceptibility. J Hosp Infect 1999; 42: 219-29.
39. Tattawasart U, Maillard J-Y, Furr JR, Russell AD. Outer membrane changes in Pseudomonas stutzeri resistant to chlorhexidine and cetylpyridinium chloride. Int J Antimicrob Agents 2000; 16: 233-38.
40. Tattawasart U, Hann AC, Maillard J-Y, Furr JR, Russell AD. Cytological changes in chlorhexidine-treated isolates of Pseudomonas stutzeri. J Antimicrob Chemother 2000; 45: 145-52.
41. Bloomfield SF. Significance of biocide use and antimicrobial resistance in domiciliary environments. J Appl Microbiol 2002; 2: 144S-57S.
42. Hammond SA, Morgan JR, Russell AD. Comparative sensitivity of hospital isolates of Gram-negative bacteria to antiseptics and disinfectants. J Hosp Infect 1987; 9: 255-64.
43. Chuanchen R, Beinlich K, Hoang TT, et al. Cross-resistance between triclosan and antibiotics in Pseudomonas aeruginosa is mediated by multidrug efflux pumps: exposure of a susceptible mutant strain to triclosan selects nfxb mutants overexpressing MexCD-Opr J. Antimicrob Agents Chemother 2001; 45: 428-32.
44. Schweizer HP. Triclosan: a widely used biocide and its link to antibiotics. FEMS Microbiol Lett 2001; 202: 1-7.
45. Higgins CS, Murtough SM, Williamson E, et al. Resistance to antibiotics and biocides among non-fermenting Gram-negative bacteria. Clin Microbiol Infect 2001; 7: 308-15.
46. Webster J, Faoagali JL, Cartwright D. Elimination of methicillin-resistant Staphylococcus aureus from a neonatal intensive care unit after hand washing with triclosan. J Paediatr Child Health 1994; 30; 59-64.
47. McBain AJ, Bartolo RG, Catrenich CE, Charbonneau D, Ledder RG, Gilbert P. Effects of a chlorhexidine-containing mouthwash on the viability and antimicrobial susceptibility of in vitro oral bacterial ecosystems. Appl Environ Microbiol 2003; 69: 4770-76.
48. Gilbert P, McBain A. Potential impact of of increased use of biocides in consumer products on the prevalence of antibiotic resistance. Clin Microbiol Rev 2003; 16: 189-208.
49. Gorbach SL. Antimicrobial use in animal feed-time to stop. N Engl J Med 2001; 345: 1202-03.
50. White DG, Zhao S, Sudler R, et al. The isolation of antibiotic-resistant salmonella from retail ground meats. N Engl J Med 2001; 345:1147-54.
51. McDonald LC, Rossiter S, Mackinson C, et al. Quinopristin-dalfopristin-resistant Enterococcus faecium on chicken and in human stool specimens. N Engl J Med 2001; 345: 1155-60.
52. Donlan RM, Costerton JW. Biofilms: survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev 2002; 15: 167-93.
53. Dunne Jr WM. Bacterial adhesion: seen any good biofilms recently? Clin Microbiol Rev 2002; 15: 155-66.
54. Williams I, Venables WA, Lloyd D, Paul F, Critchley I. The effects of adherence to silicone surfaces on antibiotic susceptibility in Staphylococcus aureus. Microbiology 1997; 143: 2407-13.
55. Stewart PS, Costerton JW. Antibiotic resistance of bacteria in biofilms. Lancet 2001; 358: 135-38.
56. Gilbert P, Das JR, Jones MV, Allison DG. Assessment of resistance towards biocides following the attachment of microorganisms to, and growth on, surfaces. J Appl Microbiol 2001; 91: 248-54.
57. Wimpenny J, Manz W, Szevqk U. Heterogeneity in biofilms. FEMS Microbiol Rev 2000; 24: 661-71.
58. Swift S, Downie JA, Whitehead NA, et al. Quorum sensing as a population-density determinant of bacteria] physiology. Adv Microb Physiol 2001; 45: 199-270.
59. Gilbert P, McBain AJ. Biocide use in the domestic setting and concern about aantibacterial and antibiotic resistance. J Infect 2001; 43: 85-91.
60. Walters MC III, Roe F, Bugnicourt A, et al. Contributions of antibiotic penetration, oxygen limitation and low metabolic activity to tolerance of Pseudomonas aeruginosa biofilms to ciprofloxacin and tobramycin. Antimicrob Agents Chemother 2003; 47: 317-23.
61. Huang CT, Fu YP, McFeters GA, Stewart PS. Non-uniform spatial patterns of respiratory activity within biofilms during disinfection. Appl Environ Microbiol 1995; 61: 2252-56.
62. Maira-Litran T, Allison DG, Gilbert P. An evaluation of the potential role of the multiple antibiotic resistance operon (mar) and the multidrug efflux pump acrAB in the resistance of escherichia coli biofilms towards ciprofloxacin. J Antimicrob Chemother 2000; 45: 789-95.
63. Gilbert P, Maira-Litran T, McBain Al, Rickard AH, Whyte F. The physiology and collective recalcitrance of microbial biofilm communities. Adv Microb Physiol 2002; 46: 205-56.
64. Lewis K. Programmed cell death in bacteria. Microbiol Mol Biol Rev. 64: 503-14.
65. Spoering AL, Lewis K. Biofilms and planktonic cells of Pseudomonas aeruginosa have similar resistance to killing by antimicrobials. J Bacteriol 2001; 183: 6746-51.
66. Whiteley M, Bangera MG, Bumgarner RE, et al. Gene expression in Pseudomonas aeruginosa biofilms. Nature 2001; 413; 860-64.
67. Li X-Z, Poole K, Nikaido H. Contributions of MexAB-OprM and an EmrE homolog to intrinsic resistance of Pseudomonas aeruginosa to aminoglycosides and dyes. Antimicrob Agents Chemother2003; 47: 27-33.
68. Akimutsu N, Hamomoto H, Inoue R, et al. Increase in resistance of methicillin-resistant Staphylococcus aureus to beta-lactams caused by mutations conferring resistance to benzalkonium chloride, a disinfectant widely used in hospitals. Antimicrob Agents Chemother 1999; 43: 3042-43.
69. McMurry LM, Oethinger M, Levy SB. mar A, soxS or acrAB produces resistance in laboratory and clinical strains of Escherichia coli. FEMS Microbiol Lett 1999; 166: 305-09.
70. Zhang Y, Heym B, Allan B, Young D, Cole S. The catalase-peroxide gene and isoniazid resistance. Nature 1992; 358: 591-93.
71. Bannerjee A, Dubnau E, Quemard A, et al. InhA, a gene encoding a target for isoniazid and ethionamide in Mycobacterium tuberculosis. Science 1994; 263: 227-30.
72. Sidhu MS, Heir E, Leegaard T, Wiger K, Holck E, Frequency of disinfectant resistance genes and genetic linkage with β-lactamase transposon Tn 552 among clinical staphylococci. Antimicrob Agents Chemother 2002; 46: 2797-803.
73. Heir E, Sundheim G, Holck AL. The qacG gene on plasmid pST94 confers resistance to quaternary ammonium compounds in staphylococci isolated from the food industry. J Appl Microbiol 1999; 86: 378-88.
74. Bjorland J, Sunde M, Waage S. Plasmid-borne smr gene causes resistance to quaternary ammonium compounds in bovine Staphylococcus aureus. J Clin Microbiol 2001; 39: 3999-4004.
75. Sidhu MS, Heir E, Sorum H, Holck A. Genetic linkage between resistance to quaternary ammonium compounds and β-lactam antibiotics in food-related Staphylococcus spp. Microb Drug Resist 2001; 7: 363-71.
76. Anthonisen I-L, Sunde M, Steimum TM, Sidhu MS, Sorum H. Organization of the antiseptic resistance gene qacA and Tn552-related β-lactamase genes in multidrug-resistant Staphylococcus haemolyticus strains of animal amd human origin. Antimicrob Agents Chemother 2002; 46: 3606-12.
77. Paulsen IT, Skurray RA. Topology, structure and evolution of two families of proteins involved in antibiotic resistance and antiseptic resistance in eukaryotes-an analysis. Gene 1993; 124: 1-11.
78. Cookson BD, Bolton MC, Platt JH. Chlorhexidine resistance in methicillin-resistant Staphylococcus aureusorjust an elevated MIC? An in vitro and in vivo assessment. Antimicrob Agents Chemother 1991; 35: 1997-2002.
79. Mayer S, Boos M, Beter A, Fluit AC, Schmitz F-J. Distribution of the antiseptic resistance genes qacA, qacB and qacC in 497 methicillin-resistant European isolates of Staphylococcus aureus. J Antimicrob Chemother 2001; 47: 896-97.
80. Reverdy ME, Bes M, Nervi C, Martra A, Fleurette J. Activity of four antiseptics (acriflavine, benzalkonium chloride, chlorhexidine digluconate and hexamidine di-isethionate) and of ethidium bromide on 392 strains representing 26 Staphylococcus species. Med Microbiol Lett 1992; 1: 56-63.
81. Sasatsu M, Shidata Y, Noguchi N, Kono M. Substrates and inhibitors of antiseptic resistance in Staphylococcus aureus. Biol Pharm Bull 1994; 17: 163-65.
82. Paulsen IT, Brown MH, Skurray RA. Characteristaics of the earliest known Staphylococcus aureus plasmid encoding a multidrug efflux system. J Bacteriol 1998; 180: 3477-79.
83. Jones RD, Jampani HB, Neman JL, Lee AS. Triclosan: a review of effectiveness and safety in health care settings. Am J Infect Control 2000; 28: 184-96.
84. Beinlich KI, Chuanchen R, Schweizer HP. Contribution of multidrug efflux pumps to multiple antibiotic resistance in veterinary isolates of Pseudomonas aeruginosa. FEMS Microbiol Lett 2001; 198: 129-34.
85. Stickler DJ, Thomas B, Clayton CL, Chawla JC. Studies on the genetic basis of chlorhexidine resistance. Br J Clin Pract, Symp Suppl 1983; 25: 23-30.
86. Stickler DJ. Susceptibility of antibiotic-resistant Gram-negative bacteria to biocides: a perspective from the study of catheter biofilms. J Appl Microbiol 2002; 92: 163S-70S.
87. Koljalj S, Naaber P, Mikelsaar M. Antibiotic resistance as an indicator of bactertial chlorhexidine susceptibility. J Hosp Infect 2002; 51: 106-13.
88. Lambert RJW, Joynson J, Forbes B. The relationships and susceptibilities of some industrial, laboratory and clinical isolates of pseudomonas aeruginosa to some antibiotics and biocides. J Appl Microbiol 2001; 91: 972-84.
89. Joynson JA, Forbes B, Lambert RJW. Adaptive resistance to benzalkonium chloride, amikacin and tobramycin: the effect on susceptibility to other antimicrobials. J Appl Microbiol 2002; 93: 96-106.
90. Lambert RJW, Graf JF, Sedlak RI. Antimicrobial resistance and cross-resistaance in several bacterial species between 1989 and 2000. ICAAC, San Diego; 2002: Abstract C2-1127.
91. Marshall BM, Robleto E, Dumont T, et al. The frequency of bacteria and antibiotic resistance in homes that use and do not use surface antibacterial agents. 103rd general meeting, American Society for Microbiology, Washington DC; 2003: Abstract A-147.
92. Lear JC, Maillard J-Y, Dettmar PW, Goddard PA, Russell AD. Chloroxylenol-and triclosan-tolerant bacteria from industrial sources. J Indust Microbiol Biotechnol 2002; 29: 238-42.
93. McBain AJ, Rickard AH, Gilbert P. Possible implications of biocide accumulation in the environment on the prevalence of bacterial antibiotic resistance. J Ind Microbiol Biotechnol 2002; 29: 326-30.
94. Griffiths AJF, Miller JH, Suzuki DT, Lewontin RC, Gelbart WM. An introduction to genetic analysis, 7th edn. New York: WH Freeman, 1999.
95. Wichelhaus TA, Boddinghaus B, Besier S, et al. Biological cost of rifampicin resistance from the perspective of Staphylococcus aureus. Antimicrob Agents Chemother 2002; 46: 3381-85.
96. Gillespie SH. Antibiotic resistance in the absence of selective pressure. Int J Antimicrob Agents 2001; 17: 171-76.
97. Lenski RE, Simpson SC, Nguyen TT. Genetic analysis of a plasmid-encoded, host genotype-specific enhancement of bacterial fitness. J Bacteriol 1994; 176: 3140-47.
98. Schrag SJ, Perrot V, Levin BR. Adaptation to the fitness costs of antibiotic resistance in Escherichia coli. Proc R Soc Lond B Biol Sci 1997; 264: 1287-91.
99. Davies A, Billington O, Bannister BA, et al. Comparison of fitness of two isolates of Mycobacterium tuberculosis, one of which had developed multi-drug resistance during the course of treatment. J Infect 2000; 41: 184-87.
100. Roche WA, Foster PL. Mutation under stress: adaptive mutation in Escherichia coli. In: Storz G, Hengge-Aronis R, eds. Bacterial stress responses. Washington, DC: ASM Press, 2000: 239-48.
101. Finkel SE, Zinser ER, Kolter R. Long-term survival and evolution in the stationary phase. In: Storz G, Hengge-Aronis R, eds. Bacterial stress responses. Washington, DC: ASM Press, 2000: 231-38.
102. White DG, McDermott PF. Biocides, drug resistance and microbial evolution. Curr Opin Microbiol 2001; 4: 313-17.
103. Baquero F, Negri MC, Morosini MI, Blazquez J. Antibiotic-selective environments. Clin Infect Dis 1998; 27 (suppl 1): S5-11.
104. Baquero F, Patron C, Canton C, Ferrer MM. Laboratory and in-vitro testing of skin antiseptics: a prediction for in-vivo activity. J Hosp Infect 1991; 18 (suppl B): 5-11.
105. Tenover FC, McGowen JE. Reasons for the emergence of antibiotic resistance. Am J Med Sci 1996; 311: 9-16.
106. Walsh SE, Maillard J-Y, Russell AD, et al. Activity and mechanisms of action of selected biocidal agents on Gram-positive and -negative bacteria. J Appl Microbiol 2003; 94: 240-47.
107. Cozad A, Jones RD. Disinfection and the prevention of infectious disease. Am J Infect Control 2003; 31: 243-54.
108. Murtough SM, Hiom SJ, Palmer M, Russell AD. Biocide rotation in the healthcare setting: is there a case for policy implementation? J Hosp Infect 2001; 48: 1-6.
109. Chambers ST. Resistance to antimicrobial agents: can we make a difference? Adverse Drug React Toxicol Rey 2000; 19: 207-21.
110. Douglas MW, Mulholland K, Denyer V, Gottlieb T. Multi-drug resistant Pseudomonas aeruginosa outbreak in a burns unit-an infection control study. Burns 2001; 27: 131-35.
111. Kollef MH, Fraser VJ. Antibiotic resistance in the intensive care unit. Ann Intern Med 2001; 134: 299-314.
112. Block C, Furman M. Association between intensity of chlorhexidine and microorganisms of reduced susceptibility in a hospital environment. J Hosp Infect 2002; 51: 201-06.
113. Gebel J, Sonntag HG, Werner HP, et al. The higher disinfectant resistance of nosocomial isolates of Klebsiella oxytoca: how reliable are indicator organisms in disinfectant testing? J Hosp Infect 2002; 50: 309-11.
114. Loughlin MF, Jones MV, Lambert PA. Pseudomonas aeruginosa adapted to benzalkonium chloride show resistance to other membrane-active agents but not to clinically relevant antibiotics. J Antimicrob Chemother 2002; 46: 631-39.
115. Levy SB. Antibiotic and antiseptic resistance: impact on public health. Pediatr Infect Dis J 2000; 19: S120-S22.
116. Levy SB. Antibacterial household products: cause for concern. Emerg Infect Dis 2001; 7 (suppl 3): 512-15.
117. Tambe SM, Sampath L, Modak SM. In vitro evaluation of the risk of developing bacterial resistance to antiseptics and antibiotics used in medical devices. J Antimicrob Chemotherapy 2001; 47: 589-98.
118. Braid JJ, Wale MCJ. The antibacterial activity of triclosan-impregnated storage boxes against Staphylococcus aureus, Escherichia coli, Pseudomonas aeruginosa, Bacillus subtilis and Shewanella putrefaciens in conditions simulating domestic use. J Antimicrob Chemother 2002; 49: 87-94.
119. Bordas AC, Brady MS, Siewierski M, Katz SE. In vitro enhancement of antibiotic resistance development-interaction of residue levels of pesticides and antibiotics. J Food Prot 1997; 60: 531-36.
120. Moken MC, McMurry LM, Levy SB. Selection of multi-antibiotic-resistant (Mar) mutants of Escherichia coli by using the disinfectant pine oil: roles of the mar and acrAB loci. Antimicrob Agents Chemother 1997; 41: 2770-72.
121. Chapman JS. Characterizing bacterial resistance to preswervatives and disinfectants. Int Biodet Biodeg 1998; 41: 241-45.
122. Chapman JS, Diehl MA, Fearnside KJ. Preservative tolerance and resistance. Int J Cosmet Sci 1998; 19: 1-10.
123. Holland KT Bojar RA. Cosmetics. What is their influence on the skin microflora? Am J Clin Dermatol 2002; 3: 445-49.
124. Russell AD. Shifting the emphasis: are biocides safer? Ann Dermatol Venereol 2002; 129: 1486.
125. Larson E. Hygiene of the skin: when is clean too clean? Emerg Infect Dis 2001; 7: 225-30.
126. Stewart PS. Mechanisms of antibiotic resistance in bacterial biofilms. Int J Med Microbiol 2002; 292: 107-13.
127. Campanac C, Pineau, Payard A, et al. Interactions between biocide cationic agents and bacterial biofilms. Antimicrob Agents Chemother 2002; 46: 1469-74.
128. Heath RJ, Rock CO. A triclosan-resistant bacterial enzyme. Nature 2000; 406: 145-46.
129. Meade MJ, Waddell RL, Callahan TM. Soil bacteria Pseudomonas putida and Alcaligenes xylosoxidans subsp denitrificans inactivate triclosan in liquid and solid substrates. FEMS Microbiol Lett 2001; 204: 45-48.
130. Guertin-Mechin L, Dubois-Brissonnet, Heyd B, Leveau JY. Quaternary ammomium, stresses induce a specific variations in fatty acid composition of Pseudomonas aeruginosa. Int J Food Microbiol 2000; 55: 157-59.